‘Number to treat’ with UDCA may improve survival rates in PBC

While the absolute clinical efficacy of ursodeoxycholic acid for primary biliary cholangitis varied by baseline prognostic characteristics, study results showed generally high rates of liver transplant-free survival and overall survival.“These results provide a clear understanding of the clinical importance of optimized UDCA therapy for patients and doctors, thereby stimulating compliance and treatment uptake,” Maren H. Harms, PhD student, from Erasmus University Medical Center in the Netherlands, and colleagues wrote.Harms and colleagues designed this study to determine theRead More

Share on facebook
Share on twitter
Share on linkedin